Solventum Reports Strong Q1 Adjusted EPS, Raises Full-Year Guidance to High End of Range
Summary
Solventum reported first-quarter 2026 adjusted diluted EPS of $1.48, a 10.6% increase year-over-year, exceeding expectations, and affirmed full-year organic sales growth while projecting adjusted EPS toward the high end of its guidance range.
Key Events
-
Q1 Adjusted EPS Beat
Reported adjusted diluted EPS of $1.48, a 10.6% increase year-over-year, surpassing expectations.
-
Full-Year Guidance Raised
Affirmed full-year 2026 organic sales growth guidance and now expects adjusted EPS to be toward the high end of the existing $6.40 to $6.60 range.
-
Organic Sales Growth
Achieved 2.1% organic sales growth in Q1 2026, reflecting strong performance across all reportable segments.
-
GAAP and Cash Flow Decline
GAAP diluted EPS decreased by 91.0% to $0.07, and free cash flow was negative $(273) million, primarily due to separation activities and seasonality.
Analysis
This 8-K officially releases Solventum's first-quarter 2026 financial results, confirming the positive adjusted earnings per share and organic sales growth previously reported by news outlets. While GAAP diluted EPS saw a significant decline and free cash flow was negative, the company's adjusted performance and upward revision of its full-year adjusted EPS guidance indicate operational strength and confidence in its transformation initiatives. Investors will likely focus on the adjusted metrics and the reaffirmed full-year outlook, which suggests a stable trajectory despite the GAAP and cash flow headwinds attributed to separation activities and seasonality.
At the time of this filing, SOLV was trading at $67.07 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $12B. The 52-week trading range was $62.38 to $88.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.